Finance

Lists
Why is TVRD down 3.85%?
Dive Deeper
TVRD:NASDAQ
Tvardi Therapeutics Inc
$ 1.00
-3.85%
(-0.040) 1D
$ 1.00
0.00% (0.00)
After hours
Closed: 10-р сарын 14, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TVRD...
Open
$ 1.01
High
$ 1.03
Low
$ 0.99
Mkt. cap
13.34 сая
Avg. vol.
202.97 мян
Volume
75.72 мян
52-wk high
$ 7.23
52-wk low
$ 0.93
EPS
-$ 2.78
Beta
0.37
Shares outstanding
13.34 сая
No. of employees
12
Open
$ 1.01
High
$ 1.03
Low
$ 0.99
Mkt. cap
13.34 сая
Avg. vol.
202.97 мян
Volume
75.72 мян
52-wk high
$ 7.23
52-wk low
$ 0.93
EPS
-$ 2.78
Beta
0.37
Shares outstanding
13.34 сая
No. of employees
12
News stories
From web sources and news partners
About Tvardi Therapeutics Inc
CEO-
Employees12
Founded2017
HeadquartersШугар Ланд, Техас, Америкийн Нэгдсэн Улс
SectorPharmaceutical industry
Analyst ratings
Based on 6 analysts giving stock ratings to TVRD in the past 3 months
Buy
Buy
4
Hold
1
Sell
1
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for TVRD in the last 3 months.
Highest
Current $ 1.00
$ 14.00 (+1,300.00%)
Average
$ 8.20 (+720.00%)
Lowest
$ 3.00 (+200.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Debanjana Chatterjee
JonesTrading
Buy
Reiterated
$ 10.00
+900%
09/15/2026
Elemer Piros
Lucid Capital
Buy
Initiated
$ 14.00
+1,300%
09/08/2026
Sara Nik
H.C. Wainwright
Buy
Maintained
$ 9.00
+800%
08/21/2026
Unknown Analyst
Cantor Fitzgerald
Hold
Maintained
-
-
08/19/2026
Julian Harrison
BTIG
Buy
Maintained
$ 5.00
+400%
08/19/2026
Etzer Darout
Barclays
Sell
Maintained
$ 3.00
+200%
08/20/2026
Yasmeen Rahimi
Piper Sandler
Buy
Upgraded
$ 13.00
+1,200%
07/08/2026
Ryan Deschner
Raymond James
Buy
Upgraded
$ 10.00
+900%
07/08/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
$ 10.00
+900%
05/11/2026
Jay Olson
Oppenheimer
Buy
Maintained
$ 10.00
+900%
05/11/2026
Steven Seedhouse
Cantor Fitzgerald
Hold
Maintained
-
-
04/01/2026
Christopher Liu
Lucid Capital
Buy
Upgraded
$ 6.00
+500%
02/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.60 сая
5.49 сая
4.91 сая
4.00 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.34 сая
2.10 сая
2.14 сая
2.63 сая
Operating expense
5.94 сая
7.59 сая
7.05 сая
6.63 сая
Total operating expenses
5.94 сая
7.59 сая
7.05 сая
6.63 сая
Operating income
-5.94 сая
-7.59 сая
-7.05 сая
-6.63 сая
Other non operating income
-
-
-
-
EBT including unusual items
-5.53 сая
-7.28 сая
-6.80 сая
-6.46 сая
EBT excluding unusual items
-5.53 сая
-7.28 сая
-6.80 сая
-6.46 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.53 сая
-7.28 сая
-6.80 сая
-6.46 сая
Net profit margin
-
-
-
-
Earnings per share
-0.59
-0.78
-0.73
-0.69
Interest and investment income
411.00 мян
312.00 мян
247.00 мян
172.00 мян
Interest expense
-
-
-
-
Net interest expenses
411.00 мян
312.00 мян
247.00 мян
172.00 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.91 сая
-7.56 сая
-7.03 сая
-6.61 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс